MedPage Today -- Both the duration and composition of hormone therapy (HT) significantly influenced breast cancer risk in postmenopausal women, long-term follow-up in almost 3,000 women showed.
MedPage Today -- Both the duration and composition of hormone therapy (HT) significantly influenced breast cancer risk in postmenopausal women, long-term follow-up in almost 3,000 women showed.